" class="no-js "lang="en-US"> Remidio - Medtech Alert
Thursday, November 30, 2023
Remidio | Pharmtech Focus


About Remidio


Remidio is an innovative ISO 13485 certified medical device company that seeks to create Healthcare Access by combining the simplicity of product design with cutting edge technology and sustainable business model innovations. Remidio uses principles of Design Thinking and involves key stakeholders during the product development process – clinicians, patients, and health workers, with a view to designing product solutions that are simple to use, clinically relevant, reliable, and scalable. Remidio’s CE marked and FDA 510k registered retinal imaging devices have helped screen and impact more than 7.5 million patients in 15 countries globally, as a result of increased access provided by the ease of use and affordability of Remidio’s patented optics on the smartphone platform.

Related Story

Remidio's Medios AI Shows Significant Promise in Last-mile Screening for Referable Glaucoma

July 8 2022

Glaucoma, one of the world’s leading causes of irreversible blindness, is expected to affect an […]